Broadening the Phenotypic Range of Xq28 Duplications Involving MECP2: A Case Study from a Family - Top-Institutions - MDSpire

Broadening the Phenotypic Range of Xq28 Duplications Involving MECP2: A Case Study from a Family

  • By

  • Katerina Gaberova

  • Iliyana Hristova Pacheva

  • Ralitsa Yordanova

  • Tihomir Todorov

  • Albena Todorova

  • Liliyana Grozdanova

  • Margarita Panova

  • Mariyana Georgieva

  • Ivan Stefanov Ivanov

  • April 22, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Baylor College of Medicine
    Baylor College of Medicine

    Houston, TX

    Key Differentiators

    • Medical Genetics
    • Neurodevelopmental Disorders
    • Genomic Medicine

  • #2

    Boston Children's Hospital / Harvard Medical School
    Boston Children's Hospital / Harvard Medical School

    Boston, MA

    Key Differentiators

    • Pediatric Neurology
    • Medical Genetics
    • Neurodevelopmental Disorders

  • #3

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Medical Genetics
    • Neurogenetics
    • Pediatric Neurology

  • #4

    The Kennedy Krieger Institute / Johns Hopkins University
    The Kennedy Krieger Institute / Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Neurodevelopmental Disorders
    • Medical Genetics
    • Pediatric Neurology

Original Source(s)

Broadening the Phenotypic Range of Xq28 Duplications Involving MECP2: A Case Study from a Family

  • by Katerina Gaberova, Iliyana Hristova Pacheva, Ralitsa Yordanova, Tihomir Todorov, Albena Todorova, Liliyana Grozdanova, Margarita Panova, Mariyana Georgieva, Ivan Stefanov Ivanov

  • April 22, 2026

Related Content

GLP-1 Drugs Linked to GI Effects, Uncertain Signals

Umbrella review evaluates over 1,700 trials to assess noncardiometabolic outcomes beyond weight and glycemic effects.

This Week’s CGT News: Novo’s Parkinson’s Pivot

Novo Nordisk’s Parkinson’s cell therapy finds a new home at Cellular Intelligence, while base editing, prime editing, and large-insertion genome writing push forward

  • May 18, 2026

  • 7 min
IQSEC2-related developmental and epileptic encephalopathy with a Rett-like phenotype: two cases with novel variants and a review of the literature